Buparlisib is an orally bioavailable and selective pan-class I phosphatidylinositol-3 kinase (PI3K) inhibitor.
This report contains market size and forecasts of Buparlisib in global, including the following market information:
Global Buparlisib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Buparlisib Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Buparlisib companies in 2021 (%)
The global Buparlisib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Buparlisib include Selleck Chemicals, Abcam, BOC Sciences, Syd Labs, Santa Cruz Biotechnology, Cayman Chemical, BioVision, Shimadzu and Biosynth Carbosynth, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Buparlisib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Buparlisib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Buparlisib Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Buparlisib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Buparlisib Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Buparlisib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Buparlisib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Buparlisib revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Buparlisib revenues share in global market, 2021 (%)
Key companies Buparlisib sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Buparlisib sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Selleck Chemicals
Abcam
BOC Sciences
Syd Labs
Santa Cruz Biotechnology
Cayman Chemical
BioVision
Shimadzu
Biosynth Carbosynth
Adooq Bioscience
Axon Medchem
TargetMol
Enzo Biochem
LGC
LKT Laboratories
InvivoChem
J&K Scientific